Cytokines (such as PTHrP, interleukin (IL)-1, IL-6, and IL-8) derived from cancer cells could activate osteoclasts and subsequently activate the RANKL/RANK pathway which had been proven to be correlated with poor prognosis in cancer patients (30, 31). This evidence concerns the gene IL6 and cancer.